XML 50 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Loss Before Income Taxes
For the years ended December 31, 2023, 2022, and 2021, our loss before income taxes was comprised of the following (in thousands):

Year Ended December 31,
202320222021
Domestic$(89,925)$(102,434)$(48,743)
Foreign(18,307)(47,794)(39,120)
Total$(108,232)$(150,228)$(87,863)
Schedule of Components of Income Tax Expense
For the years ended December 31, 2023, 2022, and 2021, our income tax expense was comprised of the following (in thousands):
Year Ended December 31,
202320222021
Current:
Federal$34 $72 $15 
State223 119 79 
Foreign4,523 1,409 1,156 
Total current expense4,780 1,600 1,250 
Deferred:
Federal— — — 
State— — — 
Foreign(1,571)(908)(472)
Total deferred benefit(1,571)(908)(472)
Total income tax expense$3,209 $692 $778 
Schedule of Reconciliation of Statutory to Effective Income Tax Rate
For the years ended December 31, 2023, 2022, and 2021, the provision for income taxes differs from the amount computed by applying the federal statutory income tax rates to our loss before the provision for income taxes as follows:

Year Ended December 31,
202320222021
U.S. federal statutory tax rate21.0 %21.0 %21.0 %
State tax expense3.8 4.1 4.7 
Foreign rate differential(3.1)(3.3)(4.1)
Nondeductible expenses(0.7)(0.3)(0.5)
Foreign tax expense(0.4)0.3 (0.2)
Equity compensation(2.4)1.0 7.0 
Tax credits9.5 4.7 5.0 
Unrecognized tax benefits(1.8)(0.9)(0.9)
Change in tax rate(0.9)0.3 (1.2)
Other0.2 (0.5)(0.1)
Deferred adjustments(3.0)(0.8)0.9 
Change in valuation allowance(25.2)(26.1)(32.5)
Total(3.0)%(0.5)%(0.9)%
Schedule of Deferred Tax Assets and Liabilities
As of December 31, 2023 and 2022, significant components of our deferred tax assets and liabilities were as follows (in thousands):

As of December 31,
20232022
Deferred tax assets:
Net operating losses$103,299 $85,442 
Tax credits29,582 21,215 
Deferred revenue861 416 
Equity compensation4,879 5,314 
Lease liabilities18,822 17,732 
Accrued compensation3,323 4,510 
Bad debt447 656 
Other accrued expense218 16 
Capitalized research and development costs35,047 29,991 
Other1,369 431 
Gross deferred tax assets197,847 165,723 
Less: Valuation allowance(161,966)(132,581)
Total deferred tax assets35,881 33,142 
Deferred tax liabilities:
Prepaid expenses(16,505)(15,309)
Right-of-use assets(10,626)(10,056)
Depreciation(3,779)(4,275)
Intangible assets(1,179)(1,540)
Other(341)(123)
Total deferred tax liabilities(32,430)(31,303)
Net deferred tax assets$3,451 $1,839 
Schedule of Valuation Allowance The following table summarizes the activity related to our valuation allowances for the years ended December 31, 2023, 2022, and 2021 (in thousands):
Year Ended December 31,
202320222021
Beginning balance
$132,581 $94,399 $65,914 
Charged to expense
27,267 39,203 28,450 
Foreign currency translation adjustments
2,118 (1,021)35 
Deductions from reserve
— — — 
Ending balance
$161,966 $132,581 $94,399 
Schedule of Activity Related to Unrecognized Tax Benefit The following table summarizes the activity related to our unrecognized tax benefit from December 31, 2020 to December 31, 2023 (in thousands):
Balance as of December 31, 2020
$2,277 
Additions for tax positions in current years 812 
Additions for tax positions in prior years — 
Reductions due to lapse in statutes of limitations — 
Settlements — 
Balance as of December 31, 2021
3,089 
Additions for tax positions in current years 1,399 
Additions for tax positions in prior years — 
Reductions due to lapse in statutes of limitations — 
Settlements — 
Balance as of December 31, 2022
4,488 
Additions for tax positions in current years 1,740 
Additions for tax positions in prior years 256 
Reductions due to lapse in statutes of limitations — 
Settlements — 
Balance as of December 31, 2023
$6,484